Epidemiology of vitiligo in the French West Indies (Isle of Martinique)

International Journal of Dermatology

Volumn 39, Issue 1, 2000, Pages 18-20

  Boisseau Garsaud, Anne Marie ^a,b   Garsaud, Philippe ^a   Calès Quist, Danielle ^a   Hélénon, Raymond ^a   Quénéhervé, Catherine ^a   Claire, Romule Charles Sainte ^a  

^a Centre Hospitalier Universitaire   (Martinique)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CHILD; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREVALENCE; PROSPECTIVE STUDY; PSORIASIS; THYROID DISEASE; VITILIGO;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MARTINIQUE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; VITILIGO;

EID: 0034006858     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2000.00880.x     Document Type: Article

References (20)

1. Lerner A. On the etiology of vitiligo and gray hair. Am J Med 1971; 51: 141-147.
2. Service Statistique Régional, Ministère des Affaires Sociales, de la Santé et de la Ville. Statistiques Santé -Affaires Sociales, Région Sanitaire Antilles-Guyane. Fort de France: Atelier, 1994: 1-47.
3. Lerner AB. Vitiligo. J Invest Dermatol 1959; 32: 285-310.
4. Mosher DB, Fitzpatrick TB, Ortonne JP, Honi Y. Disorders of pigmentation. In: Fitzpatrick TB, Eisen AZ, Wolff K, eds. Dermatology in General Medicine. New York: McGraw Hill, 1987: 794-876.
5. Nath SK, Majumder PP, Norlund JJ. Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am J Hum Genet 1994; 55: 981-990.
6. Nordlund JJ, Majumder PP. Recent investigations on vitiligo vulgaris. Dermatol Clin 1997; 15: 69-78.
7. Le Poole IC, Das PK, Van Den Wijngaard RMJBJ, et al. Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 1993; 2: 145-153.
8. Howitz J, Brodthagen H, Schwanz M, Thomsen K. Prevalence of vitiligo: epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol 1977; 113: 47-52.
9. Das SK, Majumder PP, Chakraborty R, et al. Studies on vitiligo. I. Epidemiological profile in Calcutta, India. Genet Epidemiol 1985; 2: 71-78.
10. Singh M, Singh G, Kanwar AJ, Belhaj MS. Clinical pattern of vitiligo in Libya. Int J Dermatol 1985; 24: 233-235.
11. George AO. Vitiligo in Ibadan, Nigeria. Incidence, presentation, and problems in management. Int J Dermatol 1989; 28: 385-387.
12. Mehta NR, Shah KC, Theodore C, et al. Epidemiological study of vitiligo in Surat area. Indian J Med Res 1973; 61: 145-154.
13. Nordlund JJ, Halder RM, Grimes P. Management of vitiligo. Dermatol Clin 1993; 11: 27-33.
14. Bhatia PS, Mohan L, Pandey ON, et al. Genetic nature of vitiligo. J Dermatol Sci 1992; 4: 180-184.
15. Bor S, Feiwel M, Chanarin L. Vitiligo and its aetiological relationship to organ-specific autoimmune diseases. Br J Dermatol 1969; 81: 83-88.
16. Cunliffe WJ, Hall R, Newell DJ, Stevenson CJ. Vitiligo, thyroid disease and autoimmunity. Br J Dermatol 1968; 80: 135-139.
17. Finco O, Cuccia M, Martinetti M, et al. Age of onset in vitiligo; relationship with HLA supratypes. Clin Genet 1991; 39: 48-54.
18. McGregor BC, Karz HI, Doe RP. Vitiligo and multiple glandular insufficiencies. JAMA 1972; 219: 724-725.
19. Shallreuter KU, Lemke R, Brandt O, et al. Vitiligo and other diseases: coexistence or true association? Dermatol 1994; 188: 269-275.
20. Ortonne JP, Perrot H, Thivolet J. Etude clinique et statistique d'une population de 100 vitiligos. II -Associations lésionnelles. Sem Hop Paris 1976; 52: 679-686.